These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 2061375)
1. High-performance liquid chromatographic method for the determination of the three main oxidative and 3-carboxylic antipyrine metabolites in human urine. Palette C; Cordonnier P; Naline E; Advenier C; Pays M J Chromatogr; 1991 Jan; 563(1):103-13. PubMed ID: 2061375 [TBL] [Abstract][Full Text] [Related]
2. Assay of antipyrine and its main metabolites 3-hydroxymethylantipyrine, norantipyrine and 4-hydroxyantipyrine in urine. Brendel E; Meineke I; de Mey C J Pharm Biomed Anal; 1989; 7(12):1783-90. PubMed ID: 2490567 [TBL] [Abstract][Full Text] [Related]
3. Antipyrine metabolism in man: simultaneous determination of norantipyrine and 4-hydroxyantipyrine in urine by gas chromatography. Inaba T; Fischer NE Can J Physiol Pharmacol; 1980 Jan; 58(1):17-21. PubMed ID: 7378903 [TBL] [Abstract][Full Text] [Related]
4. Automated high-performance liquid chromatographic determination of antipyrine and its main metabolites in plasma, saliva and urine, including 4,4'-dihydroxyantipyrine. Teunissen MW; Meerburg-van der Torren JE; Vermeulen NP; Breimer DD J Chromatogr; 1983 Dec; 278(2):367-78. PubMed ID: 6668316 [TBL] [Abstract][Full Text] [Related]
5. Improved high-performance liquid chromatographic assay of antipyrine, hydroxymethylantipyrine, 4-hydroxyantipyrine and norantipyrine in urine. Mikati MA; Szabo GK; Pylilo RJ; LeDuc BW; Browne TR; Greenblatt DJ J Chromatogr; 1988 Dec; 433():305-11. PubMed ID: 3235560 [No Abstract] [Full Text] [Related]
6. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation. Engel G; Hofmann U; Heidemann H; Cosme J; Eichelbaum M Clin Pharmacol Ther; 1996 Jun; 59(6):613-23. PubMed ID: 8681486 [TBL] [Abstract][Full Text] [Related]
7. Studies on the different metabolic pathways of antipyrine in rats: influence of phenobarbital and 3-methylcholanthrene treatment. Danhof M; Krom DP; Breimer DD Xenobiotica; 1979 Nov; 9(11):695-702. PubMed ID: 119355 [TBL] [Abstract][Full Text] [Related]
8. The pharmacokinetics of antipyrine and three of its metabolites in the rabbit: intravenous administration of pure metabolites. St Peter JV; Abul-Hajj Y; Awni WM Pharm Res; 1991 Dec; 8(12):1470-6. PubMed ID: 1808608 [TBL] [Abstract][Full Text] [Related]
9. Automated high-performance liqiud chromatographic method for the determination of antipyrine and its metabolites in urine. Some preliminary results obtained from smokers and non-smokers. Nakagawa A; Nakamura K; Ishizaki T; Chiba K J Chromatogr; 1982 Sep; 231(2):349-60. PubMed ID: 7130315 [TBL] [Abstract][Full Text] [Related]
10. Simultaneous determination of antipyrine, 4-hydroxyantipyrine, 3-hydroxymethylantipyrine and norantipyrine in urine by gas chromatography chemical ionization mass spectrometry. Tang BK; Uchino H; Inaba T; Kalow W Biomed Mass Spectrom; 1982 Oct; 9(10):425-8. PubMed ID: 7171741 [TBL] [Abstract][Full Text] [Related]
11. Quantitation of norantipyrine sulphate and norantipyrine glucuronide as major metabolites of antipyrine in man and rat. Böttcher J; Bässmann H; Schüppel R J Pharm Pharmacol; 1984 Jun; 36(6):391-8. PubMed ID: 6146671 [TBL] [Abstract][Full Text] [Related]
12. The pharmacokinetics of mefloquine in man: lack of effect of mefloquine on antipyrine metabolism. Rivière JH; Back DJ; Breckenridge AM; Howells RE Br J Clin Pharmacol; 1985 Nov; 20(5):469-74. PubMed ID: 3878153 [TBL] [Abstract][Full Text] [Related]
13. Human metabolism of antipyrine labelled with 14C in the pyrazolone ring or in the N-methyl group. Uchino H; Inaba T; Kalow W Xenobiotica; 1983 Mar; 13(3):155-62. PubMed ID: 6613161 [TBL] [Abstract][Full Text] [Related]
14. Antipyrine metabolite formation in children in the acute phase of malnutrition and after recovery. Buchanan N; Davis M; Danhof M; Breimer DD Br J Clin Pharmacol; 1980 Oct; 10(4):363-8. PubMed ID: 7448107 [TBL] [Abstract][Full Text] [Related]
16. Solid phase extraction and simultaneous high performance liquid chromatographic determination of antipyrine and its major metabolites in urine. Sarkar MA; March C; Karnes HT Biomed Chromatogr; 1992; 6(6):300-4. PubMed ID: 1286289 [TBL] [Abstract][Full Text] [Related]
17. Antipyrine clearance and metabolism in patients with psoriasis. Kubota K; Ishizaki T; Chiba K; Takagi A; Nakagawa A; Nakamura K Br J Clin Pharmacol; 1986 Oct; 22(4):455-62. PubMed ID: 3768257 [TBL] [Abstract][Full Text] [Related]
18. Elimination studies of antipyrine and its metabolites in healthy Saudi Arabians. Ali HA; el-Yazigi A; Sieck JO; Døssing M; Saour J; Raines DA; Ernst P Hum Exp Toxicol; 1994 Oct; 13(10):658-62. PubMed ID: 7826682 [TBL] [Abstract][Full Text] [Related]
19. The effect of verapamil on antipyrine pharmacokinetics and metabolism in man. Bach D; Blevins R; Kerner N; Rubenfire M; Edwards DJ Br J Clin Pharmacol; 1986 Jun; 21(6):655-9. PubMed ID: 3741715 [TBL] [Abstract][Full Text] [Related]
20. Correlation between antipyrine metabolite formation and theophylline metabolism in humans after simultaneous single-dose administration and at steady state. Teunissen MW; De Leede LG; Boeijinga JK; Breimer DD J Pharmacol Exp Ther; 1985 Jun; 233(3):770-5. PubMed ID: 4009489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]